glp-1 modulation by probiotics scientific evidence Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases GLP-1 and GLP-2 Orchestrate Intestine

however, the market scenario has shifted focus towards oral GLP-1 receptor agonists, incretin agonists, triple agonists, and amylin-based approaches targeting obesity as a metabolic disease rather than merely focusing on its weight management

Cold Spring Harbor Perspectives in Biology, 6(1)

Journal of immunology (Baltimore, Md: 1950) 2008;181:4780-90

A 10-minute session can torch 100-130 calories and improve coordination

Whether this distinct property of saxagliptin could interact with pathways of bone metabolism and bone turnover, thus having a relatively negative impact on bone mass or strength, needs to be elucidated